Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Leeds Institute of Medical Research at St James’s

1 abstract

Abstract
A disease registry study to prospectively observe treatment patterns and outcomes in patients with HER2+ unresectable locally advanced or metastatic breast cancer (aBC): Interim results of the ESTHER study (NCT02393924).
Org: Roche Products Limited, Cmed Clinical Research Services, Leeds Institute of Medical Research at St James’s, Kent Oncology Centre, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research,